Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides von Davis, Peter D, Hill, Christopher H, Lawton, Geoffrey, Nixon, John S, Wilkinson, Sandra E, Hurst, Steven A, Keech, Elizabeth, Turner, Susan E

Volltext

Phosphorylation of SLP-76 by the ZAP-70 Protein-tyrosine Kinase Is Required for T-cell Receptor Function von Wardenburg, Juliane Bubeck, Fu, Chong, Jackman, Janet K., Flotow, Horst, Wilkinson, Sandra E., Williams, David H., Johnson, Robin, Kong, Guanghui, Chan, Andrew C., Findell, Paul R.

Volltext

Potent selective inhibitors of protein kinase C von Davis, Peter D., Hill, Christopher H., Keech, Elizabeth, Lawton, Geoffrey, Nixon, John S., Sedgwick, Anthony D., Wadsworth, Julie, Westmacott, Donald, Wilkinson, Sandra E.

Volltext

Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity von Davis, Peter D, Elliott, Lucy H, Harris, William, Hill, Christopher H, Hurst, Steven A, Keech, Elizabeth, Kumar, M. K. Hari, Lawton, Geoffrey, Nixon, John S, Wilkinson, Sandra E

Volltext

Protein kinase C: is its pivotal role in cellular activation over-stated? von Wilkinson, Sandra E., Hallam, Trevor J.

Volltext

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction von Bit, Rino A., Davis, Peter D., Elliott, Lucy H., Harris, William, Hill, Christopher H., Keech, Elizabeth, Kumar, Hari, Lawton, Geoffrey, Maw, Anna, Nixon, John S., Vesey, David R., Wadsworth, Julie, Wilkinson, Sandra E.

Volltext

Selective tyrosine kinase inhibitors von Wilkinson, Sandra E, Harris, William

Volltext

Therapeutic potential of protein kinase C inhibitors von Bradshaw, David, Hill, Christopher H., Nixon, John S., Wilkinson, Sandra E.

Volltext

K252a is a potent and selective inhibitor of phosphorylase kinase von Elliott, Lucy H., Wilkinson, Sandra E., Sedgwick, Anthony D., Hill, Christopher H., Lawton, Geoffrey, Davis, Peter D., Nixon, John S.

Volltext

Different Sensitivities of Neutrophil Responses to a Selective Protein Kinase C Inhibitor, Ro 31-8425; Redundancy in Signal Transduction von Merritt, Janet E., Sullivan, John A., Tse, Jenny, Wilkinson, Sandra E., Nixon, John S.

Volltext

Protein Kinase C: Measurement of Translocation, Activation, and Role in Cellular Responses von Wilkinson, Sandra E., Hallam, Trevor J.

Volltext

A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli von Muid, Robert E., Dale, M.Maureen, Davis, Peter D., Elliott, Lucy H., Hill, Christopher H., Kumar, Hari, Lawton, Geoffrey, Twomey, Breda M., Wadsworth, Julie, Wilkinson, Sandra E., Nixon, John S.

Volltext

Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain von Davis, Peter D., Hallam, Trevor J., Harris, William, Hill, Christopher H., Lawton, Geoffrey, Nixon, John S., Smith, Janet L., Vesey, David R., Wilkinson, Sandra E.

Volltext

FKBP, thought to be identical to PKCI-2, does not inhibit protein kinase C von Albers, Mark W., Liu, Jun, Wilkinson, Sandra E., Wadsworth, Julie, Perez-Sala, Dolores, Rando, Robert R., Nixon, John S., Schreiber, Stuart L.

Volltext

The inhibitory profiles of hog pancreatic and human rheumatoid synovial cell phospholipases A2 von Nixon, John S., Wilkinson, Sandra E., Davis, Peter, Bloxham, David P.

Volltext

A Single Dose of Vitamin D Enhances Immunity to Mycobacteria von Martineau, Adrian R, Wilkinson, Robert J, Wilkinson, Katalin A, Newton, Sandra M, Kampmann, Beate, Hall, Bridget M, Packe, Geoffrey E, Davidson, Robert N, Eldridge, Sandra M, Maunsell, Zoe J, Rainbow, Sandra J, Berry, Jacqueline L, Griffiths, Christopher J

Volltext

Neutrophil-mediated innate immune resistance to mycobacteria von Martineau, Adrian R, Newton, Sandra M, Wilkinson, Katalin A, Kampmann, Beate, Hall, Bridget M, Nawroly, Niga, Packe, Geoffrey E, Davidson, Robert N, Griffiths, Christopher J, Wilkinson, Robert J

Volltext

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial von Monk, Phillip D, Marsden, Richard J, Tear, Victoria J, Brookes, Jody, Batten, Toby N, Mankowski, Marcin, Gabbay, Felicity J, Davies, Donna E, Holgate, Stephen T, Ho, Ling-Pei, Clark, Tristan, Djukanovic, Ratko, Wilkinson, Tom M A, Crooks, Michael G, Dosanjh, Davinder PS, Siddiqui, Salman, Rahman, Najib M, Smith, Jacklyn A, Horsley, Alexander, Harrison, Timothy W, Saralaya, Dinesh, McGarvey, Lorcan, Watson, Alastair, Foster, Edmund, Fleet, Adam, Singh, Dave, Hemmings, Sophie, Aitken, Sandra, Dudley, Sarah, Beegan, Rona, Thompson, Angela, Rodrigues, Pedro MB

Volltext

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor von Lazaar, Aili L., Yang, Lucy, Boardley, Rebecca L., Goyal, Navin S., Robertson, Jonathan, Baldwin, Sandra J., Newby, David E., Wilkinson, Ian B., Tal‐Singer, Ruth, Mayer, Ruth J., Cheriyan, Joseph

Volltext

IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37 von Martineau, Adrian R, Wilkinson, Katalin A, Newton, Sandra M, Floto, R Andres, Norman, Anthony W, Skolimowska, Keira, Davidson, Robert N, Sørensen, Ole E, Kampmann, Beate, Griffiths, Christopher J, Wilkinson, Robert J

Volltext